Pseudomonas aeruginosa Consumption of Airway Metabolites Promotes Lung Infection

Area of Science:

• Microbiology
• Immunology
• Pulmonology

Background:

• Cystic fibrosis (CF) lung infections are complex, with mucus trapping pathogens.
• The selection of specific opportunistic pathogens like Pseudomonas aeruginosa in CF lungs remains poorly understood.
• Factors beyond mucus accumulation likely contribute to chronic bacterial disease in CF airways.

Purpose of the Study:

• To review the role of macrophage metabolites, specifically succinate and itaconate, in Pseudomonas aeruginosa pneumonia within the context of CF.
• To analyze how CF transmembrane conductance regulator (CFTR) dysfunction influences metabolite release and P. aeruginosa pathogenesis.
• To explore host and pathogen interactions involving these metabolites and suggest therapeutic considerations.

Main Methods:

• Literature review focusing on host-pathogen interactions in CF lung disease.
• Analysis of the impact of succinate and itaconate on P. aeruginosa transcriptomics and metabolism.
• Examination of CFTR's role in metabolite dysregulation in the airway.

Main Results:

• CFTR dysfunction promotes the release of succinate and itaconate into the CF airway.
• P. aeruginosa utilizes these macrophage metabolites to adapt and enhance its pathogenic potential.
• Succinate and itaconate influence bacterial gene expression and metabolic pathways, contributing to persistent infection.

Conclusions:

• Macrophage-derived succinate and itaconate are critical factors in P. aeruginosa pathogenesis in CF lungs.
• Targeting these metabolites or their pathways presents a potential therapeutic strategy for CF lung disease.
• Future research and therapies should account for the role of airway metabolite abundance in CF pathogenesis.